ERBB2 and breast cancer: False positive cases in CE-MRI were seen across all breast cancer subtypes with a similar distribution (23/63 = 27% luminal-like, 12/25 = 32% HR+/HER2+, 8/25 = 24% HR-/HER2+, 15/75 = 17% triple-negative; P = 0.21).